hereditary breast ovarian cancer
Clinical, Molecular and Geographical Features of Hereditary Breast/Ovarian Cancer in Latvia
... of hereditary breast/ovarian cancer between two historically, geographically and ethnically different regions of Latvia, the region of Liepãja and that of ...family cancer histories ...
6
Do hereditary syndrome-related gynecologic cancers have any specific features?
... which hereditary breast- ovarian cancer and hereditary non-polyposis colon cancer syndromes, known as HBOC and Lynch syndromes re- spectively, present the highest relative ...
8
Case Report Synchronous double primary gastric and endometrial cancer: a case report and literature review
... of cancer most often associat- ed with this syndrome are colorectal cancers, endometrium, ovary, small bowel, pancreas, biliary and urinary tract [13, ...of breast cancer, osteosarcoma and soft ...
6
BRACAVENIR: an observational study of expectations and coping in young women with high hereditary risk of breast and ovarian cancer
... of cancer encounter various life difficulties, notably questions concerning the future and how to build long-term ...of cancer is the standard of care, but psychosocial consequences remain unad- ...in ...
9
Population screening for hereditary and familial cancer syndromes in Valka district of Latvia
... of hereditary cancer burden by loca- tion in the same group was obtained by population ...of hereditary colorectal cancer corresponds to the wide published spectrum of 1 - 13% but is lower ...
11
Hereditary breast and ovarian cancer
... Familial breast cancer was first recognized in the Roman medical literature of 100 AD ...of breast cancer in modern times was published by Broca, who reported 10 cases of breast ...
11
Candidate genetic modifiers for breast and ovarian cancer risk in BRCA1 and BRCA2 mutation carriers.
... Helsinki Breast Cancer Study (HEBCS): We would like to thank Taru ...The Hereditary Breast and Ovarian Cancer Research Group Netherlands (HEBON) consists of the following ...
16
Lifestyle intervention in BRCA1/2 mutation carriers: study protocol for a prospective, randomized, controlled clinical feasibility trial (LIBRE-1 study)
... The goal is to recruit a minimum of 60 patients for the feasibility study. Recruitment and study conduct take place at three centers in three different regions in Germany (Munich, Kiel, and Cologne). Patients will be ...
10
BARD1 and Breast Cancer: the Possibility of Creating Screening Tests and New Preventive and Therapeutic Pathways for Predisposed Women
... of hereditary breast and ovarian cancers and site-specific breast cancer; inTP53 is associated with up to 85% risk of developing breast cancer by age 60; germline ...
13
The Prevention of Hereditary Breast and Ovarian Cancer: A Personal View
... Currently, screening is done with mammography or with MRI. Although MRI appears to be superior to mammography in early studies [9, 10], access to MRI is rare outside of research settings. The test is costly and ...
6
Medical Oncology Unit, National Cancer Research Centre, IRCCS Istituto Tumori "Giovanni Paolo II", 70124 Bari, Italy.
... BRCA-associated hereditary breast and ovarian cancer syndrome (HBOC) implies increased absolute risk also for other malignancies such as cholangiocarcinoma ...
6
Evidence for SMAD3 as a modifier of breast cancer risk in BRCA2mutation carriers
... the Breast Cancer Research Foundation (to KLN), and by the Mariann and Robert MacDonald Foundation (to ...The Hereditary Breast and Ovarian Cancer Research Group Netherlands ...
10
Genetic discrimination and life insurance: a systematic review of the evidence
... No particular genetic condition was sought after but results concerned: hereditary hemochromatosis, Huntington ’ s disease, breast and ovarian cancer, cerebral autosomal dominant arterio[r] ...
15
<p>Familial Pancreatic Cancer: Current Perspectives</p>
... STK11. Hereditary breast and ovarian cancer syndrome (HBOC) due to BRCA2 mutations is the most common form of HPC, and those genes with the highest risk of developing this neoplasm are STK11, ...
16
Screening for BRCA1, BRCA2, CHEK2, PALB2, BRIP1, RAD50, and CDH1 mutations in high risk Finnish BRCA1/2 founder mutation negative breast and/or ovarian cancer individuals
... high-risk hereditary breast and/or ovarian cancer (HBOC) BRCA1/2-founder mutation-negative Finnish individuals, were screened for germline alterations in seven breast cancer ...
13
Pilot study of decision support tools on breast cancer chemoprevention for high-risk women and healthcare providers in the primary care setting
... about breast cancer risk assessment and ...patients’ breast cancer risk, together with the ac- tion plans generated by the patients ’ interactions with RealRisks (perceived behavioral ...on ...
12
Strong evidence that the common variant S384F in BRCA2has no pathogenic relevance in hereditary breast cancer
... A large kindred with the BRCA2 variant S384F [GenBank U43746] was recruited at the Centre for Familial Breast and Ovarian Cancer located at the universities of Cologne and Bonn (Fig. 1a). Blood ...
5
Molecular genetics analysis of hereditary breast and ovarian cancer patients in India
... of breast cancer (≤35 years of age) or ovarian cancer (≤40 years of age); Two cases of breast cancer diagnosed under the age of 50 years in a family (first and second degree ...
10
Protocol for the “Implementation, adoption, and utility of family history in diverse care settings” study
... (breast cancer, colon cancer, lung cancer, ovarian cancer, hereditary cancer syndrome, hereditary cardiovascular diseases, connective tissue diseases, ...
10
Quantifying Regional-Scale Water Storage Using Models and Observations: Application For Drought Assessment In South Carolina
... 2010, cancer became the leading cause of death worldwide, with breast cancer ranked as the most commonly diagnosed cancer among women (Neal et ...of breast cancer is ...
107